TIERRA HURD: Open Payments
NPI 1679744296 · NATIONAL HARBOR, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,372 in 148 payments from 18 companies in 2025. Trend: 2023 $1,361 · 2024 $5,185 · 2025 $4,372
Food & beverage: $4,372
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 21 | $898 |
| UCB, Inc. | 17 | $691 |
| Lilly USA, LLC | 7 | $274 |
| Medimetriks Pharmaceuticals, Inc. | 12 | $266 |
| Incyte Corporation | 13 | $264 |
| Amgen Inc. | 7 | $256 |
| Novartis Pharmaceuticals Corporation | 14 | $230 |
| Regeneron Healthcare Solutions, Inc. | 4 | $212 |
| Organon LLC | 4 | $200 |
| GENZYME CORPORATION | 6 | $198 |
Products named: NEMLUVIO, Bimzelx, OPZELURA, OTEZLA, DUPIXENT, SOFDRA, VTAMA, COSENTYX.
Industry payments across MD — which companies pay providers there.
